Headed to ACS San Diego? Join us for Happy Hour!
← Back to glossary

High-Throughput Screening (HTS)

Method
Method
Method

High-throughput screening (HTS) is an experimental technique that enables the rapid testing of thousands to millions of compounds for biological activity against a specific target or cellular phenotype. Using automated robotics, sensitive detection methods, and data analysis pipelines, HTS is a foundational approach for identifying initial “hits” in drug discovery.

Importance in Computational Drug Discovery:

  • Generates large datasets for training and validating computational models, including machine learning and QSAR.
  • Provides initial hit compounds for further optimization through virtual screening and structure-based design.
  • Enables integration with cheminformatics tools for hit triaging, clustering, and SAR analysis.
  • Facilitates the identification of off-target effects and polypharmacology profiles through broad panel screens.
  • Drives the development of predictive models for compound activity, toxicity, and ADMET properties.

Key Tools

  • Pipeline Pilot: Automates HTS data processing, analysis, and visualization.
  • KNIME Analytics Platform: Enables custom workflows for HTS data integration, filtering, and modeling.
  • Dotmatics Studies: Manages and analyzes HTS campaigns and hit selection.
  • ChEMBL: Provides access to curated HTS results and bioactivity data for computational analysis.

Literature

"High-throughput screening in drug discovery"

  • Publication Date: 2006
  • DOI: 10.1007/BF02784813
  • Summary: This foundational paper discusses the role of HTS in the drug discovery process, highlighting how advancements in laboratory automation have enabled the rapid screening of large compound libraries to identify potential drug candidates.

"Adaptation of High-Throughput Screening in Drug Discovery"

  • Publication Date: 2012
  • DOI: 10.1016/j.drudis.2012.01.007
  • Summary: This review explores the evolution of HTS methodologies and their integration into modern drug discovery pipelines, emphasizing the importance of assay development and data analysis in improving screening efficiency.

"High-Throughput Screening Platforms in the Discovery of Novel Therapeutics for Neurodegenerative Diseases"

  • Publication Date: 2021
  • DOI: 10.3390/ijms22041559
  • Summary: This article reviews the application of HTS platforms in identifying potential therapeutics for neurodegenerative diseases, discussing the challenges and opportunities in targeting complex biological systems.

"Advances in High-Throughput Mass Spectrometry in Drug Discovery"

  • Publication Date: 2022
  • DOI: 10.1016/j.drudis.2022.01.007
  • Summary: This paper highlights the integration of mass spectrometry techniques into HTS workflows, enhancing the ability to analyze complex biological samples and identify bioactive compounds with greater precision.

"The Efficiency of High-Throughput Screening (HTS) and In-Silico Data Integration in Antiviral Drug Discovery"

  • Publication Date: 2025
  • DOI: 10.1016/j.drudis.2025.01.007
  • Summary: This study examines the synergistic use of HTS and computational approaches in accelerating the discovery of effective antiviral agents, demonstrating how data integration can enhance hit identification and lead optimization.